We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Generic Hepatitis C Drug Costs Just $50 to Make

News   Nov 02, 2017 | Original story from World Hepatitis Alliance

 
Generic Hepatitis C Drug Costs Just $50 to Make
 
 
 

RELATED ARTICLES

Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

News

Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.

READ MORE

Kidney Cancer Driver Could Lead to New Treatment Strategy

News

Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.

READ MORE

Targeting Headaches and Tumors with Nano-Submarines

News

Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE